These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 23022002)

  • 21. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].
    Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR
    Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urolithiasis in geriatric patients.
    Usui Y; Matsuzaki S; Matsushita K; Shima M
    Tokai J Exp Clin Med; 2003 Jul; 28(2):81-7. PubMed ID: 14714833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
    Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
    Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones.
    Asplin JR; Lingeman J; Kahnoski R; Mardis H; Parks JH; Coe FL
    J Urol; 1998 Mar; 159(3):664-8. PubMed ID: 9474121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The most important metabolic risk factors in recurrent urinary stone formers.
    Parvin M; Shakhssalim N; Basiri A; Miladipour AH; Golestan B; Mohammadi Torbati P; Azadvari M; Eftekhari S
    Urol J; 2011; 8(2):99-106. PubMed ID: 21656467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary stone analysis of 1,000 patients in southern Taiwan.
    Chou YH; Li CC; Wu WJ; Juan YS; Huang SP; Lee YC; Liu CC; Li WM; Huang CH; Chang AW
    Kaohsiung J Med Sci; 2007 Feb; 23(2):63-6. PubMed ID: 17339167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric urinary stone composition in the United States.
    Gabrielsen JS; Laciak RJ; Frank EL; McFadden M; Bates CS; Oottamasathien S; Hamilton BD; Wallis MC
    J Urol; 2012 Jun; 187(6):2182-7. PubMed ID: 22503021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical studies on the recurrence of urolithiasis: (1). Influence of diet on urinary excretion of the stone forming constituents].
    Murayama T; Taguchi H
    Hinyokika Kiyo; 1987 Sep; 33(9):1321-30. PubMed ID: 3434487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in upper urinary tract stone composition in Australia over the past 30 years.
    Lee MC; Bariol SV
    BJU Int; 2013 Nov; 112 Suppl 2():65-8. PubMed ID: 24127678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can 24-hour urine stone risk profiles predict urinary stone composition?
    Torricelli FC; De S; Liu X; Calle J; Gebreselassie S; Monga M
    J Endourol; 2014 Jun; 28(6):735-8. PubMed ID: 24460026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of patients with heterozygous cystinuria.
    Elkoushy MA; Andonian S
    Urology; 2012 Oct; 80(4):795-9. PubMed ID: 22854136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analytical evaluation of urinary calculi mineral composition].
    Machoy P
    Ann Acad Med Stetin; 1995; 41():259-71. PubMed ID: 8615550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the urinary calcium in the growth of calcium stone.
    Murayama T; Sakai N; Takano T; Yamada T
    Hinyokika Kiyo; 2004 Jul; 50(7):451-5. PubMed ID: 15334887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric Age-Related Distribution of Calcium Oxalate Monohydrate and Calcium Oxalate Dihydrate in Urinary Tract Stones: Metabolic, Gender, and Ethnic Correlates.
    Lotan P; Hendel H; Babaoff R; Tor R; Ben-Meir D; Morag R; Lifshitz D
    J Endourol; 2023 Aug; 37(8):928-934. PubMed ID: 37265145
    [No Abstract]   [Full Text] [Related]  

  • 36. Multiple sclerosis and nephrolithiasis: a matched-case comparative study.
    Ganesan V; Chen WM; Jain R; De S; Monga M
    BJU Int; 2017 Jun; 119(6):919-925. PubMed ID: 28220601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of serum biochemical metabolic panel with stone composition.
    Moreira DM; Friedlander JI; Carons A; Hartman C; Leavitt DA; Smith AD; Okeke Z
    Int J Urol; 2015 Feb; 22(2):195-9. PubMed ID: 25257446
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uric acid: an abettor or protector in calcium oxalate urolithiasis? Biochemical study in stone formers.
    Srinivasan S; Kalaiselvi P; Sakthivel R; Pragasam V; Muthu V; Varalakshmi P
    Clin Chim Acta; 2005 Mar; 353(1-2):45-51. PubMed ID: 15698589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and metabolic evaluation of Korean patients with urolithiasis.
    Park KJ; Jeon SS; Han DH; Lee SY
    Scand J Clin Lab Invest; 2011 Oct; 71(6):481-5. PubMed ID: 21714706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnostic values of urinary citrate for kidney stones in patients with primary gout].
    Wang Y; Zhang HM; Deng XR; Liu WW; Chen L; Zhao N; Zhang XH; Song ZB; Geng Y; Ji LL; Wang Y; Zhang ZL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 54(6):1134-1140. PubMed ID: 36533345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.